baber/WOPTO huggingface dataset:
Patent NZ-505389-A (NZ)
Title: Toilet grab rail support for children , the elderly , and the disabled
Inventor: KELLEHER HELEN JOY
IPC: A47K17/02
Filed: 1998-11-27
Abstract: A toilet bowl (2), having a seat (7) held by bolts passing through a rear portion (4) of the toilet bowl, is provided with a grab rail support comprising a mounting portion (3) secured by bolts and side rails (8) rigidly connected to the mounting portion and extending forwards close to the outer surface of the toilet bowl. Near the front of the toilet bowl, side rails curve upwardly and are configured to form rigid hand pieces, which can be gripped by persons lowering themselves onto and raising themselves from the toilet seat.
Patent NZ-506094-A (NZ)
Title: Flexible, halogen-free, radio-frequency sealable multilayer films comprising a polar ethylene copolymer layer and a non-polar olefin layer
Inventor: PETTERSSON ING-MARI GUNNEL
IPC: C08L23/08
Filed: 2000-08-01
Abstract: A halogen-free, high frequency sealable multiplayer film comprising at least; a) a polar layer having a dielectric loss factor of at least 0.10 comprising an ethylene copolymer with carbon monoxide (CO) wherein the CO comprises at least 3 percent by weight of the polar layer; and b) a layer comprising a non-polar olefin homopolymer or a non-polar olefin copolymer. The sealable film may also be comprised of a blend of at least two olefin polymers wherein one olefin polymer is a non-polar olefin homopolymer or a non-polar olefin copolymer and at least one olefin polymer has polymerized at least ethylene and carbon monoxide.  The carbon monoxide is present in at least three percent by weight of the polymer.  This blend also having a dielectric loss factor of at least 0.10.
Patent NZ-508011-A (NZ)
Title: Compounds that inhibit phosphodiesterase activity which results in potentiation of cAMP or cGMP to promote smooth muscle vasodilation
Inventor: MAW GRAHAM NIGEL
IPC: A61K38/55
Filed: 2000-11-07
Abstract: A pharmaceutical composition and a method of treatment of female sexual dysfunction (FSD), in particular female sexual arousal disorder (FSAD). Also described is a method of screening compounds useful in the treatment of FSD, in particular FSAD. The preferred embodiment describes the use of a PDE inhibitor (cyclic nucleotide phosphodiesterase inhibitor).
Patent NZ-511885-A (NZ)
Title: 2,3,4,5-tetrahydro-1H-[1,4]benzodiazephine-3-hydroxamic acid as matrix metalloproteinase inhibitors and as inhibitors of TNF-alpha converting enzyme (TACE)
Inventor: LEVIN JEREMY IAN
IPC: A61P29/00
Filed: 2000-01-27
Abstract: Compounds having formula (1) that are useful in treating disease conditions mediated by matrix metalloproteinases and TNF-alpha converting enzyme (TACE), such as tumor growth, osteoarthritis, rheumatoid arthritis and degenerative cartilage loss are disclosed, wherein R R1, R2, R3 and R4 are as described in the specification.
Patent NZ-512090-A (NZ)
Title: Apparatus and method for welding pipes together
Inventor: BELLONI ANTONIO
IPC: B23K9/127
Filed: 1999-12-21
Abstract: Apparatus (10) and method of forming a deep-sea pipeline or a cross-country pipeline by welding pipes together to form the pipeline. Two pipes (2, 4) are arranged so that their ends (26, 27) define a circumferentially extending narrow angled (less than 10 degrees) groove (28). At least two arc-welding torches (1) are arranged directly adjacent to each other on a single carriage that moves around the pipes, to form a twin arc welding system. The arcs of the torches (1) form a weld (3) in the groove. The carriage is moved around the pipe, the torches thus moving around the pipe with the same speed. Each torch (1) is independently oscillated so that the position of its arc oscillates between the walls of the groove. The arcs are guided automatically by an electronic guidance system, wherein electrical characteristics (such as arc current or voltage) of the welding of each torch (1) with regard to each pipe (2, 4), respectively, are ascertained and a comparison made between the electrical characteristics relating to one of the pipes with the corresponding electrical characteristics relating to the other of the pipes. The position of an arc of a torch (1) may thus be aligned with the centre line of the groove (28).
Patent NZ-513826-A (NZ)
Title: C 16 unsaturated FP-selective prostaglandins analogs
Inventor: DELONG MITCHELL ANTHONY
IPC: C07C405/00
Filed: 2000-02-29
Abstract: Compounds having a structure according to the following formula:are effective in treating disorders such as bone disorders and glaucoma in a subject in need thereof.
Patent NZ-515547-A (NZ)
Title: A plastics moulded clip for pivotably mounting a blade in a louvre window assembly and a louvre window control assembly
Inventor: BOON TIMOTHY TAN KOK
IPC: E06B7/086
Filed: 2001-11-19
Abstract: A plastics moulded clip (102) for pivotably mounting a blade in a louvre window assembly (100), the clip includes a pivot mount for attachment to a pivot coupling, which is a part of a pivot-effecting mechanism, the clip further includes a continuous surface wiping means which extends from one end of the clip to the other, the surface wiping means includes at least one curved rib. A louvre window control assembly which is an element of a louvre window arrangement, includes a support surface, a plurality of louvre clips, each clip which is designed as described above includes a channel to accommodate a louvre blade therein, each louvre clip is pivotally attached to a respective pivot coupling, each pivot coupling is a metal bearing (200) interconnected to a respective louvre clip such that pivotal movement of the bearing results in corresponding pivotal movement of the louvre clip, the bearing includes: a single recess (201) which has a star shape and a plurality of outer bearing surfaces and a plurality of inner bearing surfaces, each bearing surface located in between respective ones of the outer bearing surfaces, the recess is shaped to receive a complimentary protrusion (205) of the louvre clip which has corresponding outer and inner bearing surfaces engageable with the inner and outer surfaces of the recess respectively, each pivot coupling is attached to the support surface, and at least a pair of rivets fixed to the pivot coupling and serving to pivotally secure a back of the pivot coupling to respective ones of a pair of parallel control arms, each rivet has a base and a solid shaft to serve as a means bearing against a part of the pivot coupling to which the rivet is applied.
Patent NZ-516515-A (NZ)
Title: Operator's station for a lift truck with two sets of pedals at different levels, operable simultaneously, to provide flexiblilty of operation
Inventor: HENSHAW ROBERT JOSEPH
IPC: B66F9/075
Filed: 1998-08-26
Abstract: An operator's station for a materials handling vehicle, said operator's station including a floor and comprising: a first set of pedals on said floor; and a second set of pedals raised above said floor wherein said first set of pedals and said second set of pedals are both simultaneously operable so that an operator in said operator's station can operate one of said first set of pedals and one of said second set of pedals to provide flexibility of operation positions.
Patent NZ-517424-A (NZ)
Title: Pharmaceutically active sulfonamide derivatives
Inventor: ARKINSTALL STEPHEN
IPC: A61K31/52
Filed: 2000-09-28
Abstract: Sulfonamides of formula (I) that modulate the activity of the JNK function, their preparation thereof, and the use of such compounds in treating neuronal disorders.
Patent NZ-524262-A (NZ)
Title: Anticoagulants inhibiting factor XA activity
Inventor: CAPPI MICHAEL W
IPC: A61K31/496
Filed: 2001-08-23
Abstract: A compound of formula (I) is described wherein: X is Cl, Br or R1-N-CH(-NH2)-; R1 is H, -OH, -C(=O)OR2, alkyl, aralkyl, aralkyloxy or a heteroalkyl group; R2 is alkyl, heteroalkyl, a carbocyclic group, heterocycloalkyl, aryl, heteroaryl, heteroarylalkyl or aralkyl; Ar is arylene, heteroarylene, heteroarylalkylene or aralkylene, X being bonded directly to the aromatic ring system; R3 is H, alkyl, heteroalkyl or aralkyl; R4 are independently alkyl groups that may be substituted by one or more -OH or -NH2 radicals, or are heteroalkyl groups, carbocyclic groups, heterocycloalkyl groups, aryl groups, heteroaryl groups or aralkyl groups, it being possible for those groups to be substituted by one or more unsubstituted groups selected from alkyl, heteroalkyl, a carbocyclic group, heterocycloalkyl, aryl, heteroaryl and aralkyl, or are hydroxyl groups or glycosyloxy groups; n is an integer from 0 to 5; R5 is H, alkyl, heteroalkyl, a carbocyclic group, heterocycloalkyl, aryl, heteroaryl, heteroarylalkyl or aralkyl; R6 and R7 independently of each other are H, alkyl, heteroalkyl, a carbocyclic group, heterocycloalkyl, aryl, heteroaryl, aralkyl or heteroarylalkyl, it being possible for those groups to be substituted by one or more groups selected from alkyl, heteroalkyl, a carbocyclic group, heterocycloalkyl, aryl, heteroaryl, heteroarylalkyl, aralkyl, -OH and -NH2, or together form part of a heterocycloalkyl ring system, or a heteroaryl ring system, it being possible for those systems to be substituted by one or more groups selected from alkyl, heteroalkyl, a carbocyclic group, heterocycloalkyl, aryl, heteroaryl, heteroarylalkyl, aralkyl, -OH and -NH2; and R8 is H, alkyl, heteroalkyl, a carbocyclic group, heterocycloalkyl, aryl, heteroaryl, heteroarylalkyl or aralkyl or, together with R5 forms part of a heterocycloalkyl ring system. Pharmaceutical compositions can comprise the compound for use in the treatment or prevention of thromboembolic condition, arterial restenosis, septicaemia, cancer, acute inflammation and other conditions mediated by factor Xa activity.
Patent NZ-525480-A (NZ)
Title: Compositions and methods for the discovery and selection of biological information
Inventor: KHODADOUST MEHRAN M
IPC: C12N5/08
Filed: 2001-10-26
Abstract: Disclosed herein is a method of selecting for one or more cells having a specific response to a stimulatory agent of interest that comprises the steps of: (a) inserting a vector including a cassette comprising an internal ribosome entry site, a positive selection marker, a negative selection marker, and a reporter gene into eukaryotic cells; and (b) selecting cells in which expression of said reporter gene is specifically activated by said stimulatory agent.
Patent NZ-529027-A (NZ)
Title: SPA audio system operable with a remote control
Inventor: MACEY STEPHEN S
IPC: H04H20/88
Filed: 2002-02-20
Abstract: In a spa having a flexible shell (16) for holding water, an audio system for the spa comprises: a) a first transceiver (13) coupled to a source (12) of audio signals disposed at a location other than the spa; b)  a second transceiver for receiving signals from the first transceiver ; c) an audio transducer (19) attached to the flexible shell for coupling sound vibration energy to the shell, and coupled to receive signals from the second transceiver. d)  a remote control unit (10) for sending control signals to the second transceiver.
Patent NZ-533078-A (NZ)
Title: Preventing or treating diseases associated with allergies, autoimmunity and adhesion, metastatic and coronary cascades using complex carbohydrates, in particular hyaluronic acid
Inventor: BROWN HAROLD G
IPC: A61K31/728
Filed: 2001-07-31
Abstract: A way of preventing and treating diseases and conditions associated with allergies, autoimmunity, the adhesion cascade, the metastatic cascade or the coronary cascade is described. The treatment comprises administering (i) at least one complex carbohydrate as the sole active ingredient, or (ii) at least one pharmaceutical composition which comprises as an active ingredient a pharmacologically effective amount of at least one low purity or cosmetic grade complex carbohydrate selected from the group consisting of oligosaccharides, sialylated oligosaccharides, polysaccharides and glycosaminoglycans, and an effective amount of at least one transdermal or transmucosal carrier in an amount effective to deliver the complex carbohydrate into the blood stream. (62) Divided Out of 524076
Patent NZ-533603-A (NZ)
Title: Alpha-(N-sulphonamido)acetamide derivatives as beta-amyloid inhibitors used for treating Alzheimer's Disease and Down's syndrome
Inventor: PARKER MICHAEL F
IPC: C07D333/20
Filed: 2002-12-20
Abstract: Disclosed herein is a series of alpha-(N-sulfonamido)acetamide compounds of the formula (I) wherein R, R1, R2 and R3 are as defined in the specification, which are inhibitors of beta-amyloid peptide (beta -AP) production and are useful in the treatment of Alzheimer's Disease, Down's syndrome and other conditions affected by anti-amyloid activity.
Patent NZ-534314-A (NZ)
Title: Method of setting priority levels in a multiprogramming computer system with priority scheduling, multiprogramming computer system and program therefor
Inventor: JANSSEN BOB
IPC: G06F9/46
Filed: 2002-01-30
Abstract: Method for setting priority levels in a multiprogramming computer system (1) with priority scheduling, in which threads (15, 16, 17) of execution of each process (13, 14) have a standard priority level, comprises measuring relative use of one or more processors (2) in the system (1) by the threads (15, 16, 17) of execution of a process (13, 14), wherein the priority levels of one or more threads (15, 16, 17) of execution are lowered if their measured relative use exceeds a certain escalation threshold for the duration of an escalation time period.
Patent NZ-534535-A (NZ)
Title: Heterocyclic compounds having elastase-inhibitory activity and intermediates thereof
Inventor: SATO FUMINORI
IPC: A61K38/00
Filed: 2003-02-05
Abstract: A heterocyclic compound of formula (I) or a salt thereof; a pharmaceutical composition comprising the compound; and an elastase inhibitory agent comprising as an active ingredient the compound.
Patent NZ-536269-A (NZ)
Title: Blocking assembly with inflatable bladder typically for blocking drains and cesspits in event of chemical spills
Inventor: ORD RICHARD
Filed: 2004-11-01
Abstract: There is a stated to be a need for people who handle hazardous materials to be able to effectively and efficiently block cesspits and/or pipes of various drainage systems in circumstances of for example, a chemical or liquid spill or a gas leak so as to prevent or limit flow of the same into for example, the water table. This problem is stated to be solved through the use of a man made fluid inlet or outlet passage, blocking assembly comprising an inflatable bladder operatively linked to a fluid communication means, one aspect of the means being adapted to receive a pressurised fluid supply wherein, when a pressurised fluid passes through the fluid communication means, the bladder is adapted to inflate to block the passage in a fluid type manner. The fluid communications means has pipes that connect with each other so that rotation about an axis of one pipe causes rotation of one or more of another connected pipe.
Patent NZ-537169-A (NZ)
Title: High speed cooking device and method with jets providing different BTU delivery rates at different levels of impingement air
Inventor: JONES DOUGLAS S
IPC: A23L5/10
Filed: 2003-06-05
Abstract: A cooking device is disclosed that is capable of rapidly cooking food products such as in toasting bread products or cooking pizza. The cooking device uses air impingement from above and/or below the food product. In some cases an infrared heater is additionally used to impart a desired color and crunchiness about a surface of the food product. In some cases, a boost in thermal energy is applied to the bottom of the food product vis-a-vis the top thereof. In some cases, the boost is due to an extra heater which may be gas or electric. The device is particularly adapted for toasting bread products, cooking sandwich products (toasting the bread and heating the sandwich filler) and/or cooking pizza. Rapid cooking times are achieved by delivering more thermal energy to the top or bottom of the food product, depending on the type thereof, to give quality and speed.
Patent NZ-537877-A (NZ)
Title: New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: FRANCOTTE PIERRE
IPC: A61P25/16
Filed: 2005-01-25
Abstract: Compounds of formula (I) are disclosed. Also disclosed is a process for their preparation. Compounds of formula (I) are useful in the manufacture of medicaments for use as AMPA modulators. The described compounds are also useful in the manufacture of a medicament for use in the treatment or prevention of disorders of memory and cognition that are associated with: -age -syndromes of anxiety or depression -progressive neurodegenerative diseases -Alzheimer's disease -Parkinson's disease -Pick's disease -Huntington's chorea -Korsakoff's disease -schizophrenia -sequelae of acute neurodegenerative diseases -frontal lobe and subcortical dementias -the sequelae of ischaemia -the sequelae of epilepsy.
Patent NZ-539873-A (NZ)
Title: Novel chemical compounds, thiazolidin-4-one, thiazol-4-one
Inventor: HASEGAWA MASAICHI
IPC: A61K31/42
Filed: 2003-11-18
Abstract: This disclosure relates to compounds of formula I, wherein the variables shown in formula I are as defined in the specification, for inhibiting hYAK3 proteins and methods for treating diseases associated with the imbalance or inappropriate activity of hYAK3 proteins such as anemia, aplastic anemia, myelodysplastic syndrome, myelosuppression and cytopenia, in a mammal.
Patent NZ-540171-A (NZ)
Title: Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
Inventor: PEREZ RODRIGUEZ ROLANDO
IPC: C12N5/00
Filed: 2003-10-22
Abstract: Disclosed is a method of obtaining mammal cells which are adapted to grow in a medium free of serum and proteins. The method includes a process consisting of two adaptation steps comprising a critical protein concentration interval, in which the cells must acquire the ability to survive in a protein-free medium. There is a specific critical protein concentration interval for each cell line. Also disclosed are mammal cell lines which grow in a stable manner in a medium free of serum and proteins for over at least 40 generations. Also disclosed are clones which express anti-CD6 T1hT and EGF hR3 antireceptor humanised antibodies and the anti-CD3 T3Q chimeric antibody as well as fragments of said antibodies.
Patent NZ-540650-A (NZ)
Title: Satellite bandwidth management system and method
Inventor: WATERSON VINCENT ANTHONY
Filed: 2005-06-10
Abstract: A satellite bandwidth planning system includes the data sets for transponders and circuits of the satellite bandwidth system held in a computer memory and a display system configured to display a graphical representation 500 of the circuits 505 etc hosted on one or more transponders. A user can select a graphical representation of one of the circuits and change the position of the selected graphical representation, the changed position representing a proposed change of frequency of the circuit corresponding to the graphical representation. A bandwidth plan generator generates and outputs a bandwidth plan based on any proposed changes of frequency recorded by the user repositioning of the graphical representation of the one or more circuits. A command gateway implements the frequency changes to circuits hosted by the transponders in a concordance with the bandwidth plan that is output to the command gateway. With reference to Fig 5 progressing to Fig 6, being able to see a visual representation of the circuit frequency assignments on the interface makes it a simple matter for the user to de-fragment frequency assignments for a transponder.
Patent NZ-544979-A (NZ)
Title: Services and transactions in a telephony network
Inventor: KAHN ARI
IPC: H04M1/725
Filed: 2004-07-12
Abstract: A method of operating a telephony service on a telephony network is disclosed. The method comprises: (a) establishing and/or requesting a telephonic connection and/or a call between a caller and a call recipient; (b) receiving a command signal initiated by the caller and/or the call recipient during any phase in the call process, where the command signal comprises a data signal and/or tone transmitted from a handset of the caller or call recipient; and (c) initiating a network supported service to the caller and/or the call recipient, or initiating a network supported transaction between the caller and the call recipient in response to receiving the command signal, where the command signal is other than a standard call connect and/or disconnect command.
Patent NZ-550976-A (NZ)
Title: Compositions comprising cyclopropenes, molecular encapsulation agents and non-hydrocarbon oils
Inventor: BASEL RICHARD M
Filed: 2006-11-01
Abstract: Disclosed herein is a composition comprising: (a) one or more molecular encapsulation agents within each of which is encapsulated one or more cyclopropenes of formula (I), wherein R is hydrogen or a substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, phenyl, or naphthyl group; wherein the substituents, when present, are independently halogen, alkoxy, or substituted or unsubstituted phenoxy; (b) one or more non-hydrocarbon oils such as fatty acid triglycerides and silicone oil; and (c) optionally, one or more adjuvants selected from the group consisting of surfactants, alcohols, and mixtures thereof; and Also provided is a method that includes the step of contacting such compositions with one or more plants or plant parts for improving the effectiveness of cyclopropenes at blocking the effects of ethylene.
Patent NZ-551418-A (NZ)
Title: Use of flibanserin in the treatment of premenstrual disorders
Inventor: PYKE ROBERT
IPC: A61K31/496
Filed: 2005-04-18
Abstract: Disclosed is the use of flibanserin, optionally in the form of a pharmacologically acceptable acid addition salt, for the preparation of a medicament for the treatment of a premenstrual disorder.
Patent NZ-553323-A (NZ)
Title: Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile, also named TMC278
Inventor: STEVENS PAUL THEODOOR AGNES
IPC: A61P31/18
Filed: 2005-09-02
Abstract: Disclosed is the hydrochloride salt of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile, also known as TMC278. The compound is useful for the treatment of HIV infections.
Patent NZ-553521-A (NZ)
Title: Improvements relating to meningococcal outer membrane vesicles and their use in vaccines
Inventor: OSTER PHILIPP
IPC: C07K16/12
Filed: 2005-09-05
Abstract: Discloses is a composition comprising an admixture of outer membrane vesicles from two or three of: (i) a serosubtype P1.7b,4 meningococcus; (ii) a serosubtype P1.7,16 meningococcus; and (iii) a serosubtype P1.19,15 meningococcus. Further disclosed is the use of the composition in the manufacture of a medicament for use in immunisation against meningococcal meningitis and kits comprising said vaccine.
Patent NZ-565333-A (NZ)
Title: Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents
Inventor: STOREY ANTHONY EAMON
IPC: G21C1/00
Filed: 2006-08-11
Abstract: Disclosed is a process for preparation of a fluoroanilide of formula (I): wherein R1 is selected from alkyl, alkenyl, and alkynyl; which comprises: (i) reaction of a corresponding arylamide of formula (II): wherein R2 is selected from hydrogen, alkyl, haloalkyl, aryl, arylalkyl, -(CH2CH2O)q-CH3 wherein q is an integer of from 1 to 10; R1 is as defined for the compound of formula (I); and R3 is a leaving group; with fluoride to give a compound of formula (III) wherein R1 and R2 are as defined for the compound of formula (I); followed by step (ii) where step (ii) is conversion of group -C(O)R2 to hydrogen. Also disclosed is a compound of formula (IIa) or (IIb) in particular 2-[3-nitro-4-(methylformylamino)phenyl]-6-ethoxymethoxy-benzothiazole.